InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Winton Matthew. Director active across 1 company, notably Inozyme Pharma, Inc.. Aggregated, 3 filings have been logged. History available since 28 March 2024. The latest transaction was disclosed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations